ClinConnect ClinConnect Logo
Search / Trial NCT06596551

Aspirational Rehabilitation Coaching for Holistic Health (ARCH): A Pilot Pre-Post Experimental Study

Launched by NANYANG TECHNOLOGICAL UNIVERSITY · Sep 11, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

ClinConnect Summary

The ARCH trial is studying a new program called Aspirational Rehabilitation Coaching, designed to support first-time stroke survivors and their family caregivers after they leave the hospital. This program combines education, emotional support, and practices that promote self-compassion to help participants deal with the challenges they face in their mental and emotional well-being. The goal is to improve their quality of life, resilience, and ability to feel hopeful and independent.

To join the study, participants must be at least 21 years old, recovering from their first stroke, and able to communicate in English or Mandarin. They should have mild to moderate stroke symptoms and have been discharged from the hospital within the last three months. Each participant also needs a family caregiver who can join them in the program. Throughout the study, participants can expect to engage in various supportive activities that aim to enhance their emotional health and strengthen their relationship with their caregiver. This trial is currently recruiting participants, and it is important to note that individuals with severe cognitive issues or language difficulties may not be eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 21 years and above
  • Recovering from their first stroke at mild to moderate degree of severity
  • Discharged from inpatient care at no later than 3 months,
  • Clinically assessed to have cognitive capacities to engage in and complete the research study,
  • Language capabilities in English or Mandarin, and
  • One identified primary family caregiver aged 21 years and above with similar language capabilities.
  • Exclusion Criteria:
  • Families with survivors suffering from aphasia,
  • Being too ill to participate,
  • Experiencing moderate to severe cognitive impairment, and
  • With family caregivers who are not interested to participate.

About Nanyang Technological University

Nanyang Technological University (NTU) is a leading research-intensive institution located in Singapore, renowned for its commitment to advancing knowledge and innovation across various fields, including healthcare and biomedical sciences. As a clinical trial sponsor, NTU leverages its cutting-edge research capabilities and interdisciplinary expertise to facilitate groundbreaking clinical studies aimed at improving patient outcomes and enhancing medical practices. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to ensure rigorous scientific methodologies and ethical standards are upheld throughout the research process. NTU's focus on translating research findings into real-world applications positions it at the forefront of medical advancements and contributes significantly to the global healthcare landscape.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported